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Down-Regulation of IL-4 Gene Transcription
and Control of Th2 Cell Differentiation
by a Mechanism Involving NFAT1
molecules, the local cytokine environment is of the ut-
most importance, since IL-12 and IFNg favor Th1 devel-
opment whereas IL-4 promotes the generation of Th2
cells (Paul and Seder, 1994; Abbas et al., 1996; Constant
and Bottomly, 1997). Concomitantly, the transcription
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et al., 1996a, 1996b; Takeda et al., 1996). Th1/Th2 devel-Boston, Massachusetts 02115
opment is also markedly dependent on genetic back-
ground: upon stimulation, T cells from BALB/c mice
tend to differentiate into Th2 cells, rendering the mice
incapable of controlling infection with the intracellularSummary
pathogen Leishmania major, while T cells from C57BL/6,
129/SvJ, and B10.D2 mice tend to differentiate into Th1Transcription factors of the NFAT family play a critical
cells, thus enabling these mice to control the diseaserole in the immune response by activating the expres-
(Hsieh et al., 1995; Reiner and Locksley, 1995).sion of cytokines and other inducible genes in antigen-
A region on chromosome 11 containing a cluster ofstimulated cells. Here we show that a member of this
genes including those encoding granulocyte-macro-family, NFAT1, is involved in down-regulating the late
phage colony-stimulating factor, IL-3, IL-4, IL-5, and IL-phase of IL-4 gene transcription, thus inhibiting T
13 has been identified as a candidate locus for the ge-helper 2 responses. Whereas stimulated T cells from
netic control of Th1/Th2 development (Gorham et al.,wild-type mice show a transient increase and then a
1996); this region is syntenic with a locus on humanrapid decline in the steady-state levels of IL-4 mRNA
chromosome 5, which had previously been linked toin vitro, the levels of IL-4 gene transcripts in NFAT1-
elevated serum IgE levels in atopic individuals (Marshdeficient T cells are maintained at high levels under
et al., 1994). IL-4 itself, because of its strong ability tothe same conditions. Consistent with this observation,
drive T helper cell differentiation along the Th2 pathway,NFAT12/2 mice are more susceptible to infection with
is considered a candidate regulatory gene in this locusLeishmania major. This report provides evidence that
(Casolaro et al., 1996). However, other genes, directlyNFAT proteins regulate not only the initiation but also
or through control of that locus, also might regulate Th1/the termination of gene transcription.
Th2 development, as demonstrated by the recent finding
that Bcl-6±deficient mice show increased expression of
Introduction Th2 cytokines, possibly through dysregulation of STAT-
responsive genes (Dent et al., 1997).
In response to antigen stimulation, naive T helper cells Activation of T lymphocytes in response to antigen
differentiate into at least two types of effector cells, stimulation requires the synthesis and activation of mul-
characterized by their distinct patterns of cytokine ex- tiple transcription factors, which determine the subse-
pression as well as theirdisparate effects on the ongoing quent program of gene expression within the cell (Hill
immune response (Mosmann and Coffman, 1989; Paul and Treisman, 1995). Two transcription factors, c-Maf
and Seder, 1994; Abbas et al., 1996). The hallmark of T and GATA-3, are reported to be selectively expressed
helper 1 (Th1) cells is the secretion of interferon-g (IFNg), in Th2 but not Th1 cells (Ho et al., 1996; Zheng and
which promotes a predominantly cell-mediated immu- Flavell, 1997). Whenexogenously expressed, both c-Maf
nity, whereas Th2 cells produce interleukin-4 (IL-4), IL-5, and GATA-3 independently enable theproduction of Th2
IL-10, and IL-13 and activate immunoglobulin E (IgE) cytokines in Th1 or B cells, suggesting a specific role
and eosinophilic responses. The initial description of for these factors in regulating Th2 cytokine synthesis.
this dichotomyof T helpercell differentiation was quickly In contrast, nuclear factors of activated T cells (NFAT)
followed by the recognition of its fundamental patho- are present in both Th1 and Th2 cells (Rooney et al.,
physiological effect on many clinical syndromes such 1994; Rooney et al., 1995) and activate the transcription
of cytokines characteristic for both cell types (Rooneyas infection, autoimmune disease, and allergy (Abbas
et al., 1995; Rao et al., 1997). Furthermore, NFAT tran-et al., 1996; Romagnani, 1997).
scriptional activity is similarly regulated during Th1/Th2Several factors have been shown to influence the phe-
development in NFAT reporter±transgenic mice (RincoÂ nnotype that a T cell acquires following its activation. In
and Flavell, 1997). In the same system, however, NFATaddition to the dose and route of administration of the
transcriptional activity is enhanced in differentiated Th2activating antigen and the engagement of costimulatory
compared to Th1 cells, perhaps because these effector
subsets differ in their expression of Fos/Jun family mem-




Numerous studies have indicated that NFAT proteins nounced in other experiments, the steady-state levels
of IL-2 transcripts were also enhanced in restimulatedare indispensable activators of several cytokine genes
NFAT12/2 compared to NFAT11/1 cells. Both cell popu-(reviewed by Rao et al., 1997), a concept supported by
lations expressed very high levels of transcripts encod-the finding that patients who are unable to generate
ing the type 1 cytokine IFNg, causing saturation of thefunctional NFAT complexes have severely impaired cy-
probe in our assay (Figure 1A). We addressed this prob-tokine synthesis (Castigli et al., 1993; Feske et al., 1996).
lem by reducing the input RNA amounts of the sameIt was therefore unexpected that mice lacking the tran-
samples by 20-fold; under these conditions, IFNg tran-scription factor NFAT1 (NFATp), the first family member
script levels in NFAT12/2 cells were at least 2- to 3-foldto be isolated and molecularly cloned, display not a
lower than those in NFAT11/1 cells (data not shown). Nocompromised but rather an enhanced immune response
difference was found in the expression of transcripts forin various experimental systems (Hodge et al., 1996b;
tumor necrosis factor-a (TNFa), TNFb, and transformingXanthoudakis et al., 1996). The four different NFAT pro-
growth factor-b, and none of the cytokine transcriptsteins identified to date show overlapping patterns of
was visible in cells that had not been restimulated withtissue expression (Hoey et al., 1995; Lyakh et al., 1996;
anti-CD3 (data not shown).Rao et al., 1997), suggesting that other NFAT family
The increase in type 2 cytokine transcripts in restimu-members might compensate for the lack of NFAT1 in
lated NFAT12/2 spleen cells was almost completelymaintaining the immunocompetent status of NFAT1-
abolished by inclusion of anti-IL-4 (or IL-12 and anti-deficient mice. Conversely, theenhancement of second-
IL-4) during the primary stimulation (Figure 1A, middle).ary immune responses (proliferation and eosinophil re-
Conversely and as expected, theaddition of IL-4 skewedcruitment) observed in NFAT1-deficient mice (Hodge et
the differentiation of NFAT1 wild-type cells toward theal., 1996b; Xanthoudakis et al., 1996) indicates that this
Th2 pathway (Figure1A, right). Measurement of cytokineNFAT family member might selectively activate genes
levels by enzyme-linked immunosorbent assay (ELISA)the products of which exert an overall inhibitory effect
indicated that supernatants of restimulated NFAT12/2on the immune response.
spleen cells contained higher levels of IL-4 and lowerHere we have further analyzed the immune responses
levels of IFNg than supernatants of restimulated NFAT11/1of NFAT12/2 mice. We show that NFAT1-deficient and
splenocytes, when differentiated under default condi-wild-type T cells differ strikingly in the kinetics of IL-4
tions or in the presence of IL-4 but not when primedgene transcription. T cells expressing or lacking NFAT1
in the presence of anti-IL-4 (Figure 1B). These resultsare identical in the early kinetics of IL-4 gene transcrip-
indicate that in the course of prolonged activation withtion and in the peak steady-state levels of IL-4 gene
the polyclonal stimulus anti-CD3, NFAT12/2 spleen andtranscripts; however, IL-4 gene transcription is rapidly
lymph node cells developed a phenotype characterizedextinguished in NFAT11/1 cells but maintained at high
by enhanced expression of type 2 cytokines as well aslevels in NFAT12/2 cells. The maintained production of
IL-2. Moreover, the development of this phenotype wasIL-4 in NFAT12/2 cells drives their differentiation into
dependent on IL-4, since it was abolished by the addi-Th2 effector cells, producing high levels of the type 2
tion of anti-IL-4 during the primary differentiation phase.cytokines IL-4, IL-5, and IL-13. Concomitantly, NFAT1-
As the initial source of IL-12, antigen-presenting cellsdeficient mice show increased susceptibility to infection
(APCs) are thought to be critical for the priming of Th1with L. major. We conclude that within the NFAT family,
cells in response to infection (Hsieh et al., 1993). It has
NFAT1 plays a unique role in regulating T helper cell
been recently proposed that APCs play a comparable
differentiation by selectively modulating the late phase
role in Th2 cell development by inducing IL-4 in naive
of IL-4 gene transcription during the immune response.
T cells via an IL-6±dependent mechanism (RincoÂ n et al.,
1997a). Conversely, the genetic background of the T
cells themselves may determine the outcome of T cell
Results differentiation under default conditions (Hsieh et al.,
1995). To separate effects intrinsic to T helper cells from
NFAT1-Deficient T Cells Preferentially Differentiate those due to APCs and other cell types, we separated
into Type 2 Effector Cells In Vitro CD41 and CD42 spleen and lymph node cells from
We determined the patterns of cytokine mRNA expres- NFAT11/1 and NFAT12/2 mice and differentiated and
sion in NFAT11/1 and NFAT12/2 T cells differentiated restimulated them independently in the absence of
and restimulated with anti-CD3 in vitro. Spleen and added cytokines with immobilized anti-CD3 alone. Un-
lymph node cells from NFAT1-deficient or wild-type der these conditions, the difference between NFAT11/1
mice were cultured for 4 days in the presence of immobi- and NFAT12/2 cells in the levels of type 2 cytokines
lized anti-CD3, rested for 2 days, and then restimulated was as pronounced in CD41 T cells as in unseparated
for 6 hr with anti-CD3. Total RNA from these cells was splenocytes (Figure 2A, compare middle and left). In
simultaneously analyzed for the presence of multiple contrast, NFAT1-deficient splenocytes depleted of CD41
cytokine transcripts using a quantitative RNase protec- T cells showed a moderate increase only in IL-13 and
tion assay. Under default conditions, with no cytokines IL-2 transcript levels, relative to comparably depleted
or antibodies other than anti-CD3 added during the pri- NFAT1-expressing cells (Figure 2A, right).
mary stimulation, NFAT12/2 cells showed a marked in- IL-4 produced by Mel-14low CD41 (ªpreactivatedº) T
crease, relative to NFAT11/1 cells, in the levels of mRNAs cells has been shown to be capable of driving Mel-14high
encoding the type 2 cytokines IL-4, IL-5, IL-10, and IL- CD41 (ªnaiveº) T cells into Th2 cells in vitro (Bradley
et al., 1991; Gollob and Coffman, 1994). We therefore13 (Figure 1A, left). Although the effect was less pro-
Maintained IL-4 Gene Transcription in NFAT12/2 Mice
851
Figure 1. NFAT1-Deficient T Cells Preferentially Differentiate into Type 2 Effector Cells In Vitro
(A) Spleen and lymph node cells of NFAT11/1 and NFAT12/2 mice were cultured for 4 days with plate-bound anti-CD3 alone (default conditions,
left) or in conditions favoring Th1 (middle) or Th2 cell development (right), rested for 48 hr, and restimulated with plate-bound anti-CD3. Six
hours after restimulation, total cellular RNA was isolated and analyzed by RNase protection assay for transcript levels of the indicated
cytokines. Protected fragments were separated on a 6% denaturing polyacrylamide gel and visualized by autoradiography. A fragment of the
housekeeping gene encoding L32 included in the multitemplate set served as an internal control. Lower exposure of the gel confirmed that
comparable amounts of RNA were loaded in each lane.
(B) Spleen and lymph node cells of NFAT11/1 and NFAT12/2 mice were cultured for 4 days with plate-bound anti-CD3 alone (left bars), anti-
CD3 plus anti-IL-4 (middle bars) or anti-CD3 plus IL-4 (right bars), rested for 48 hr, and restimulated with plate-bound anti-CD3. Supernatants
were collected 24 hr after restimulation, and IL-4 and IFNg levels determined by ELISA. Values are expressed as the means 6 SEM of three
independent experiments.
examined the cytokine profile of CD41 NFAT12/2 T cells were stimulated for various times with anti-CD3, and
total RNA was analyzed for the levels of cytokine tran-that had been sorted for high expression of Mel-14 and
then differentiated and restimulated with immobilized scripts. As shown in Figure 3A, IL-4 mRNA reached
comparable peak levels in NFAT11/1 and NFAT12/2 cellsanti-CD3 alone. These cells also showed skewing to-
ward Th2 development relative to wild-type cells (Figure 2±4 hr after stimulation. However, when the cytokine
kinetics were followed for longer times of primary stimu-2B). We conclude that NFAT1-deficient T cells preferen-
tially differentiate into Th2 cells after stimulation with lation, it became apparent that NFAT11/1 and NFAT12/2
cells differed in the late phase of IL-4 mRNA expressionimmobilized anti-CD3, and that Mel-14high CD41 T cells
are sufficient for this selective differentiation. (Figure 3B). In NFAT1-expressing cells, the early in-
crease in IL-4 mRNA was followed by a rapid decrease,
starting at 4±8 hr and approaching baseline levels byNFAT1-Deficient Spleen Cells Do Not Effectively
Down-Regulate IL-4 mRNA Expression 20±24 hr after stimulation (Figure 3B, lanes 1±4). Strik-
ingly, this was not the case in NFAT1-deficient cells,T helper cell development is known to be strikingly influ-
enced by the local cytokine environment (Paul and Se- where the levels of IL-4 transcripts peaked at 2±4 hr as
in wild-type cells but then declined only slightly andder, 1994; Abbas et al., 1996). To determine whether the
skewing toward Th2 differentiation of NFAT12/2 cells reached a plateau that was maintained throughout the
stimulation (Figure 3B, lanes 5±8). A pattern similar tocan be explained by a difference in the early production
of IL-4 or other cytokines, we examined the kinetics of that for IL-4 was seen for IL-5, IL-10, and IL-13 tran-
scripts, although the overall levels of these cytokinecytokine mRNA expression during primary stimulation.
NFAT11/1 and NFAT12/2 spleen and lymph node cells mRNAs were much lower than that of IL-4 (and too
Immunity
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Figure 2. CD41 T Cells Are Sufficient and Required for the Development of NFAT12/2 Type 2 Effector Cells
(A) Spleen and lymph node cells of NFAT11/1 and NFAT12/2 mice were left untreated or were separated into CD41 and CD42 cell populations.
Unseparated spleen and lymph node cells (left), purified CD41 T cells (middle), and the remaining CD42 cell population (right) were cultured
independently for 4 days with plate-bound anti-CD3 alone (default conditions) and then rested and restimulated, as described for Figure 1A.
Top, cytokine transcript levels analyzed by RNase protection assay; bottom, fluorescence-activated cell sorter analysis of separated cell
populations for CD4 and CD3 expression.
(B) CD41 T cells were purified from spleen and lymph node cells of NFAT11/1 and NFAT12/2 mice and further sorted on a flow cytometer for
high expression of Mel-14 (CD62L). The resulting Mel-14high CD41 NFAT11/1 or NFAT12/2 T cell populations were cultured for 4 days with
plate-bound anti-CD3 alone (default conditions) and then rested and restimulated as described for Figure 1A. Left, cytokine transcript levels
analyzed by RNase protection assay. The top and bottom panels belong to the same autoradiogram: top, longer exposure (12 hr); bottom,
shorter exposure (4 hr). Right, fluorescence-activated cell sorter analysis for Mel-14 expression of the unsorted (solid line, open) or sorted
(solid line, filled) CD41 T cell populations. Dotted line, isotype control.
low for accurate quantitation). Presumably reflecting the induction and in the peak levels attained approximately
3 hr following stimulation. This early phase was followedcontinuous high expression of IL-4 mRNA, NFAT12/2
cells showed increased expression of the Th2 cytokines in wild-type cells by a rapid and very consistent decline,
which reduced IL-4 transcript levels to 20%±25% ofIL-4, IL-5, IL-10, and IL-13 as early as 48 hr after primary
stimulation (Figure 3B, compare lanes 4 and 8). In some peak levels by 6 hr and to 10%±15% of peak levels by
12 hr. The early phase of this decline was also manifestexperiments, a slight delay in the kinetics of induction
of IL-2 and IFNg transcripts was observed in NFAT12/2 in NFAT12/2 cells, although to varying degrees (see
points at 4±6 hr); however, by 12 hr IL-4 transcript levelscompared to NFAT11/1 cells (Figure 3A), although com-
parable levels were attained by 8±20 hr in each case stabilized and were maintained at about 50%±70% of
peak level until 48 hr following stimulation. Similar kinet-(Figure 3B).
As summarized in Figure 3C, the results from several ics were observed in purified CD41 T cells (data not
shown). ELISA confirmed that supernatants of NFAT12/2experiments were quantitated by densitometry, measur-
ing IL-4 mRNA levels in NFAT11/1 and NFAT12/2 spleen spleen and lymph node cells cells stimulated for 48 hr
with anti-CD3 contained increased levels of IL-4 proteinand lymph node cells during thecourse of primary stimu-
lation with anti-CD3. Wild-type and NFAT1-deficient (Figure 3D). These results indicate that NFAT12/2 cells
indeed show increased production of IL-4 during thecells were identical in the early kinetics of IL-4 mRNA
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Figure 3. Kinetics of Induction of Cytokine mRNAs during Primary In Vitro Stimulation of NFAT11/1 and NFAT12/2 Spleen and Lymph Node
Cells
(A) and (B) Spleen and lymph node cells isolated from NFAT11/1 and NFAT12/2 mice were stimulated for 0.5±4 hr (A) or 2±48 hr (B) with plate-
bound anti-CD3. At the indicated time points, cells were harvested and the total cellular RNA analyzed for cytokine transcript levels by RNase
protection assay. Analysis of the bands representing the housekeeping genes encoding L32 and GAPDH on a lower exposure of the gel
showed that comparable amounts of RNA were loaded in each lane.
(C) In six independent experiments similar to those shown in (A) and (B), spleen and lymph node cells isolated from NFAT11/1 and NFAT12/2
mice were stimulated for varying times ranging from 0.5±48 hr with plate-bound anti-CD3. At the indicated time points, cells were harvested
and the total cellular RNA analyzed for cytokine transcript levels by RNase protection assay. IL-4 mRNA levels were quantified by densitometric
analysis and expressed relative to the level at 2 hr in the same experiment. The level of IL-4 mRNA induction at 2 hr was always comparable
between NFAT11/1 and NFAT12/2 cells. The mean values at each time point are connected by solid (NFAT11/1) or dashed (NFAT12/2) lines.
Each symbol represents one experiment.
(D) Spleen and lymph node cells isolated from NFAT11/1 and NFAT12/2 mice were stimulated for 24 or 48 hr with plate-bound anti-CD3.
Supernatants were collected at the indicated time points and IL-4 levels determined by ELISA. Values are expressed as the means 6 SEM
of four independent experiments.
first in vitro stimulation. Strikingly, the major difference stimulation, but rather in the ability of NFAT12/2 T cells
to maintain IL-4 transcripts at high levels for prolongedbetween NFAT1-deficient and wild-type T cells was not
in the peak levels of IL-4 mRNA produced 2±4 hr after times.
Immunity
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4). Thus, the maintained expression of IL-4 mRNA by
NFAT12/2 cells cannot be due solely to hyperrespon-
siveness to IL-4.
The steady-state levels of mRNA transcripts aredeter-
mined by the balance between transcription and degra-
dation. It has been established that both mechanisms
have a significant effect on cytokine mRNA levels in
stimulated cells (Lindsten et al.,1989; Dokter et al., 1993;
Umlauf et al., 1995). The maintained level of IL-4 tran-
scripts in NFAT12/2 cells could thus be related either to
continuous transcription of the IL-4 gene or to increased
posttranscriptional processing or stabilization of the
IL-4 mRNA. To distinguish between these possibilities,
we used the immunosuppressive drug cyclosporin A
(CsA) to block IL-4 gene transcription at defined time
points after activation of the cells. CsA was used in
preference to the RNA polymerase inhibitor actinomycin
D, which has been shown to affect the turnover rate of
IL-2 mRNA as well as block transcription of the gene
(Umlauf et al., 1995). CsA, by inhibiting the calcium-
dependent phosphatase calcineurin, promotes the rapid
nuclear export of NFAT proteins (Loh et al., 1996b; Shi-
basaki et al., 1996; Timmerman et al., 1996), thereby
inhibiting within 15 min the transcription of NFAT-depen-
dent genes, as previously shown for IL-2 (Shaw et al.,
1988; Umlauf et al., 1995; Timmerman et al., 1996). Since
differences in the steady-state levels of IL-4 mRNA be-
tween NFAT11/1 and NFAT12/2 cells began to be appar-
ent by 4±6 hr after stimulation (Figure 3), we reasoned
that a 4 hr activation period would be sufficient for syn-
Figure 4. The Maintained Expression of IL-4 mRNA in NFAT12/2
thesis of any inducible proteins needed for degradationSpleen and Lymph Node Cells Is Not Explained by Hyperresponsive-
or stabilization of IL-4 mRNA.ness to IL-4
We first confirmed that the transcription of IL-4 andSpleen and lymph node cells isolated from NFAT11/1 and NFAT12/2
other cytokines in NFAT1-deficient cells was still sensi-mice were stimulated for 2±48 hr with plate-bound anti-CD3 in the
presence of anti-IL-4. At the indicated time points, cells were har- tive to CsA. As demonstrated in Figure 5A, neither
vested and the total cellular RNA analyzed for cytokine transcript NFAT11/1 nor NFAT12/2 spleen cells stimulated with
levels by RNase protection assay. Analysis of the bands represent- anti-CD3 in the continuous presence of CsA showed
ing the housekeeping genes encoding L32 and GAPDH on a lower
detectable levels of IL-4 transcripts. We then used CsAexposure of the gel showed that comparable amounts of RNA were
to assess the half-life of IL-4 transcripts in NFAT11/1 andloaded in each lane.
NFAT12/2 cells (Figure 5B). The cells were stimulated for
4 hr so that equivalent peak levels of IL-4 would be
The Maintained Expression of IL-4 mRNA attained and so that any inducible proteins needed for
in NFAT1-Deficient Spleen Cells Is Regulated mRNA degradation or stabilization would be synthe-
at the Level of Gene Transcription sized. CsA was then added to the cultures; aliquots of
and Cannot Be Explained by cells were removed at hourly intervals thereafter; and
Hyperresponsiveness to IL-4 RNA was prepared and analyzed for cytokine transcripts
IL-4 is known to induce its own production by promoting by RNase protection assay. Under these conditions we
the differentiation of IL-4±producing Th2 cells (Paul and anticipated that CsA would rapidly block any ongoing
Seder, 1994; Abbas et al., 1996). Therefore the main- transcription of the IL-4 gene, so that the resulting de-
tained expression of IL-4 transcripts by NFAT12/2 T cells cline in IL-4 transcript levels would reflect only the deg-
might result from a hyperresponsiveness of these cells radation rate of preexisting transcripts.
to IL-4 produced early in the primary response. To ad- The results indicated that IL-4 mRNA declines with a
dress this point, we evaluated the kinetics of cytokine half-life of less than 1 hr under these conditions, in both
production in the presence of anti-IL-4, to block the NFAT11/1 and NFAT12/2 cells (Figure 5B, bottom). Iden-
secondary Th2-promoting effect of IL-4. Anti-IL-4 was tical results were obtained when CsA was added at 2
capable of efficiently neutralizing endogenous IL-4, hr, instead of 4 hr, after stimulation of the cells (data
since it blocked the up-regulation of Th2 cytokines in not shown). These results suggest that NFAT12/2 spleen
NFAT12/2 spleen cells stimulated for 48 hr (Figure 4). cells maintain IL-4 transcripts at high levels because of
However, the presence of anti-IL-4 did not affect the an ability to maintain a high rate of IL-4 gene transcrip-
ability of NFAT12/2 spleen cells to maintain high levels tion and not because of an ability to stabilize IL-4 tran-
of IL-4 transcripts for as long as 20 hr after primary scripts. Since we used CsA, however, we cannot rule
stimulation, nor did it affect the rapid decline of IL-4 out posttranscriptional mechanisms that are sensitive
to this drug. Of note, themeasured half-life of IL-4 mRNAtranscripts in spleen cells from NFAT11/1 mice (Figure
Maintained IL-4 Gene Transcription in NFAT12/2 Mice
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as described, in control mice of the highly susceptible
BALB/c strain (Sadick et al., 1990; Reiner and Locksley,
1995).
It is noteworthy that the course of infection differed
between NFAT12/2 mice and BALB/c mice. Whereas the
footpads of all of the BALB/c mice steadily increased
in size until they ulcerated, NFAT12/2 mice displayed
first a rapid and then a slower increase in their footpad
sizes, which approached steady state 6±7 weeks after
infection. When followed for a longer period of time, one
of the five NFAT12/2 mice in this group developed a
progressive infection, with its footpad ulcerating be-
tween 5 and 6 weeks after injection of the pathogen.
The four remaining mice, however, eventually seemed
able to control the infection, since the size of their foot-
pads slowly decreased, although this occurred several
weeks later than in NFAT11/1 mice and had not yet
Figure 5. The Maintained Expression of IL-4 mRNA in NFAT1-Defi-
reached normal levels even 12 weeks after infection.cient Cells Is Regulated at the Transcriptional Level
To confirm that the increased susceptibility of(A) Spleen and lymph node cells isolated from NFAT11/1 and
NFAT12/2 mice to L. major was reflected by increasedNFAT12/2 mice were stimulated for the indicated times with plate-
expression of IL-4, we analyzed cytokine transcriptsbound anti-CD3 alone or in the continuous presence of CsA, added
30 min prior to stimulation. At the indicated time points, cells were present in cells of the draining lymph nodes of NFAT11/1
harvested and the total cellular RNA analyzed for IL-4 transcript and NFAT12/2 mice 4 weeks after infection with L. major.
levels by RNase protection assay, as described in Figure 1. As shown in Figure 6B, lymph node cells isolated from
(B) Spleen and lymph node cells isolated from NFAT11/1 and
NFAT12/2 mice contained higher levels of IL-4 mRNANFAT12/2 mice were stimulated for 4 hr with plate-bound anti-CD3,
compared to cells from NFAT11/1 mice, whether or notand then either they were left untreated (top) or CsA was added to
they had been treated with anti-IL-4 (Figure 6B, top).the culture (bottom). Cells were harvested at the indicated time
points and the total cellular RNA analyzed for IL-4 transcript levels This finding was consistent with the in vitro observation
by RNase protection assay. Analysis of the bands representing the that the maintenance of IL-4 transcription in NFAT12/2
housekeeping genes encoding L32 and GAPDH in (A) and (B) cells was not affected by addition of anti-IL-4 to the
showed that comparable amounts of RNA were loaded in each lane.
cultures (Figure 4). Of note, no difference in mRNA levels
for IFNg was detected between the three groups (Figure
6B, bottom). We conclude that NFAT12/2 mice are more
was very short (t1/2 ,1 hr), suggesting that posttranscrip- susceptible to infection with L. major than are NFAT11/1
tional mechanisms may indeed have a major effect on mice and that this effect is potentially mediated by con-
the steady-state levels of IL-4 mRNA. tinuous expression of IL-4 during the course of the in-
fection.
NFAT1-Deficient Mice Are More Susceptible
than Wild-Type Mice to Infection
with L. major Discussion
The in vitro differentiation experiments described above
suggested that the maintained transcription of the IL-4 NFAT proteins are well established as activators of gene
transcription during the immune response (Rao et al.,gene and consequent increase in IL-4 production by
NFAT12/2 cells altered the direction of T helper cell dif- 1997). Our results provide evidence that a member of
this family, NFAT1, plays an essential down-regulatoryferentiation toward the generation of type 2 cytokine-
producing cells. To determine whether this biased differ- role in gene transcription. We show that unlike normal
mice of the same genetic background, NFAT12/2 miceentiation has pathophysiological consequences in vivo,
we used the well-studied system of infection with the are disposed toproduce cytokines of the type2 category
during the immune response. This phenotype is ob-intracellular pathogen L. major. NFAT11/1 and NFAT12/2
mice, both of mixed C57BL/6 and 129/SvJ genetic back- served both in vitro, in T cells stimulated with anti-CD3,
and in vivo, in cells taken from the draining lymph nodesgrounds, were injected with L. major in one hind footpad
and the course of the disease was followed by measur- of mice injected several weeks previously with L. major
(Figures 1 and 6B). Mechanistically, the phenotype cor-ing the lesion size. As expected from the fact that both
C57BL/6 and 129/SvJ strains are resistant to L. major relates with a pronounced difference between NFAT11/1
and NFAT12/2 mice in the late kinetics of IL-4 geneinfection (Reiner and Locksley, 1995), NFAT11/1 mice
were capable of controlling the infection: the initial slight transcription: spleencells of NFAT12/2 mice do not show
the characteristic rapid down-regulation of IL-4 mRNAswelling of their injected footpads was followed by heal-
ing within 3±4 weeks (Figure 6A). In contrast, NFAT12/2 expression observed in NFAT11/1 cells, but rather main-
tain a high level of IL-4 transcripts for up to 24 hr follow-mice developed progressive enlargement of their foot-
pads that continued for 6±7 weeks, indicating that they ing stimulation. The resulting increase in IL-4 production
by NFAT12/2 relative to NFAT11/1 cells during the initialwere not able to restrict the infection. Neutralization of
endogenously produced IL-4 completely restored the stimulation is reinforced by the well-known positive feed-
back effect of IL-4 (Paul and Seder, 1994; Abbas et al.,ability to control the disease in NFAT12/2 mice and,
Immunity
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Figure 6. NFAT1-Deficient Mice Are More Susceptible than NFAT1 Wild-Type Mice to Infection with L. major
(A) NFAT11/1 mice and NFAT12/2 mice (five mice per group) were infected with promastigotes of L. major in one hind footpad. One group of
NFAT12/2 mice was injected with the 11B11 MAb against IL-4 24 hr prior to the infection and weekly thereafter. Two groups of BALB/c mice,
treated and not treated with anti-IL-4 (three per group), were infected as controls. The sizes of both footpads of each mouse were measured
every fifth day with a metric caliper and the lesion size calculated as the difference between the injected and the uninjected footpad.
(B) NFAT11/1 and NFAT12/2 mice, treated or not treated with anti-IL-4 (three mice per group), were infected with promastigotes of L. major
in both hind footpads. Four weeks after infection, mice were sacrificed and the cells of the popliteal lymph nodes draining the lesions were
isolated and pooled within groups. Total cellular RNA was extracted immediately and analyzed for cytokine mRNA levels. The panel for IL-4
shows an exposure of the autoradiogram to a film with higher sensitivity than the panel for IFNg. Comparable amounts of RNA were loaded
in each lane, as confirmed by analysis of the bands representing the housekeeping genes encoding L32 and GAPDH.
1996), giving rise toa striking bias toward type 2 cytokine It is also unlikely that the maintained expression of
IL-4 transcripts, which is manifest as early as 6 hr afterproduction in the secondary immune response. These
results extend an independent report that NFAT12/2 stimulation (Figure 3C), results from overproduction or
down-regulation of known cytokines by NFAT12/2 cells.spleen cells show enhanced Th2 differentiation in vitro
(Hodge et al.,1996b). They mayalso explain our previous In particular, IL-4, IL-12, and IFNg are known to influence
T helper cell differentiation (Paul and Seder, 1994; Abbasobservation that NFAT12/2 mice show increased eosino-
phil recruitment in the pleural cavity in an in vivo model et al., 1996). IL-4 acts positively to enhance IL-4 produc-
tion; however, anti-IL-4 did not affect the maintainedof allergic inflammation (Xanthoudakis et al., 1996;
J. P. B. V. et al., unpublished data). In another biological expression of IL-4 gene transcripts in NFAT12/2 cells,
ruling out the possibility that NFAT12/2 cells were hyper-consequence of this bias, NFAT12/2 mice show in-
creased susceptibility to infection with L. major, ap- responsive to the low concentrations of IL-4 produced
during the initial stimulation in vitro (Figure 4). Con-proaching the susceptibility of BALB/c mice despite
their mixed C57BL/6 and 129/SvJ genetic backgrounds. versely, IFNg exerts most of its down-regulatory effects
on Th2 differentiation by inducing APCs to produce IL-It is unlikely that the observed differences in IL-4
mRNA expression are due merely to an increase in IL- 12 and by maintaining IL-12 responsiveness in T cells
(Trinchieri, 1995; Abbas et al., 1996; Szabo et al., 1997).4±producing cell populations, such as memory T cells
(Gollob and Coffman, 1994) or NK1.11 T cells (Yoshimoto However, purified CD41 populations of NFAT12/2 cells,
stimulated with plate-bound anti-CD3 in the absence ofand Paul, 1994), in NFAT12/2 versus wild-type mice. We
did not detect any significant skewing of these T cell APCs, resembled unseparated spleen cells in their abil-
ity to differentiate preferentially into type 2 cells, sug-subpopulations in NFAT12/2 mice, as judged by expres-
sion of the cell surface markers Mel-14, CD44, CD45RB, gesting that IL-12±dependent mechanisms were not in-
volved (Figure 2). Furthermore, the Th2 skewing ofCD25, CD69, and NK1.1 (A. K., unpublished data). In
particular, both memory cells and NK1.11 T cells are NFAT12/2 relative to NFAT11/1 T cells was maintained
even when IFNg or anti-IFNg were added to cultures ofreported to have a Mel-14low (ªpreactivatedº) phenotype
(Bradley et al., 1991; Gollob and Coffman, 1994; Vicari CD41 T cells during the primary differentiation phase
(A. K., unpublished data). Based on these results, weand Zlotnik, 1996); however, CD41 Mel-14high (ªnaiveº)
splenic T cells purified by cell sorting from NFAT12/2 conclude that there is an intrinsic, cell-autonomous dif-
ference in the kinetics of IL-4 gene transcription in Tmice showed the same striking increase in type 2 cyto-
kines relative to wild-type cells, as observed for unsepa- cells that express or lack NFAT1. However, our results
do not rule out the possibility that distinct, APC-depen-rated spleen cells and purified CD41 T cells (Figure 2).
Moreover, the Th2 skewing of NFAT12/2 T cells is clearly dent mechanisms also contribute to the Th2 phenotype
of NFAT12/2 mice.cell autonomous, since it is observed in CD41 T cells
stimulated with immobilized anti-CD3 in the absence of Is NFAT1 involved in the early phase of IL-4 gene
transcription? NFAT1 clearlydoes not influence thepeakAPCs.
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levels or early kinetics of IL-4 gene transcription, which a cell surface receptor typically leads to activation of
positively acting kinases as well as negatively actingappear identical in NFAT12/2 and wild-type mice. How-
ever, it is unlikely that NFAT1 plays no role whatsoever phosphatases, and a single kinase may phosphorylate
multiple target proteins in a signaling pathway, thusin activating IL-4 gene transcription: NFAT1 in nuclear
extracts binds to each of the identified NFAT sites of leading to opposing effects on cellular function (Rao,
1991; Hill and Treisman, 1995; Hunter, 1995).the IL-4 promoter (Chuvpilo et al., 1993; Szabo et al.,
1993; Ho et al., 1995; Rooney et al., 1995); NFAT1 is Examples of such inhibitory, NFAT1-regulated gene
products might include members of the recently de-capable of driving IL-4 promoter transcription in tran-
sient assays, alone or in synergy with c-Maf and NIP- scribed family of STAT-induced inhibitors of STAT sig-
naling (Endo et al., 1997; Naka et al., 1997; Starr et al.,45 (Ho et al., 1996; Hodge et al., 1996a; Luo et al., 1996);
and an early impairment of IL-4 mRNA expression has 1997); direct repressors or corepressors acting at the
level of the nuclear transcription complex; or proteinsbeen reported in an independent strain of NFAT1-defi-
cient mice (Hodge et al., 1996b). Taken together, these inducing activation-induced cell death in all T cells or
selectively in IL-4 producing cells. The latter possibilityresults indicate that NFAT1 indeed participates in IL-4
gene transcription, and this is particularly apparent un- would be consistent with the higher proliferation rate of
NFAT12/2 cells (Hodge et al., 1996b; Xanthoudakis etder conditions where NFAT1 is the predominant or lim-
iting family member in the nucleus. A second possibility al., 1996) and with the observation that spleen cells of
an independent strain of NFAT12/2 mice showed littleis that NFAT1 competes with more effective NFAT pro-
teins for binding to IL-4 promoter sitesor for cooperation or no expression of mRNA encoding Fas ligand (FasL)
when evaluated 1 hr after in vivo injection with anti-CD3with other essential transcription factors such as GATA-3,
STAT-6, or c-Maf. This hypothesis of early competition (Hodge et al., 1996b). However, several studies have
indicated that Th1 cells are more susceptible than Th2predicts that the peak levels of IL-4 mRNA attained 2±4
hr after stimulation would be much lower in wild-type cells to Fas/FasL-mediated apoptosis (Varadhachary et
al., 1997; Zhang et al., 1997); thus, if NFAT12/2 cellsthan in NFAT12/2 cells, since NFAT1 is the predominant
family member in both resting and stimulated T cells differed from wild-type cells by the absence of a Fas/
FasL-mediated apoptotic mechanism, skewing toward(Loh et al., 1996a; Xanthoudakis et al., 1996). However,
it is clear that there is no difference in the peak levels a Th1-dominated immune response would be expected,
rather than the Th2 skewing actually observed. Further-of IL-4 mRNA in NFAT12/2 versus NFAT11/1 cells (Figure
3). Furthermore, NFAT12/2 mice do not compensate for more, NFAT12/2 cells, differentiated and restimulated in
vitro, were equally capable of inducing cell death inthe lack of NFAT1 by up-regulating other NFAT proteins
(Hodge et al., 1996b; Xanthoudakis et al., 1996). The a Fas-expressing target cell line, indicating equivalent
expression of FasL (A. Marshak-Rothstein, personalthird, most intriguing possibility is that NFAT1 is equiva-
lent to the other family members in its ability to induce communication). Certainly, other pathways of activa-
tion-induced cell-death (Wong and Choi, 1997) could bethe early phase of IL-4 gene transcription, but unique
in its ability to induce the late down-regulatory phase. defective in NFAT12/2 mice, which might selectively lead
to the survival of IL-4±producing cells.The molecular mechanism by which NFAT1 exerts its
down-regulatory effects remains unknown and is the The maintained transcription of the IL-4 gene in
NFAT12/2 cells clearly has pathophysiologically relevantfocus of present investigations. When IL-4 gene tran-
scription was acutely blocked by adding CsA, the degra- consequences in vivo. Resistance to infection with L.
major had been shown to depend on the ability to gener-dation rates of IL-4 mRNA were identical in NFAT11/1
and NFAT12/2 cells (Figure 5B), suggesting that the se- ate a Th1-dominated immune response, whereas sus-
ceptibility to the disease was associated with differenti-lective down-regulation seen in wild-type cells occurred
at the transcriptional level. An intriguing possibility is ation into Th2 cytokine-producing cells (Reiner and
Locksley, 1995). As expected, NFAT12/2 mice were lessthat transcription of the entire IL-4/IL-5/IL-13 gene clus-
ter might be coordinately regulated by NFAT1, as sug- able to control local infection with L. major than wild-
type mice, consistent with increased levels of IL-4 mRNAgested by the finding that IL-5 and IL-13 transcripts
behave similarly to IL-4 transcripts (the levels of these in cells of the draining lymph nodes (Figure 6). However,
the course of the disease in NFAT12/2 mice was differenttranscripts were too low for accurate quantitation). Po-
tentially, NFAT1 itself might shut off transcription at the from that seen in mice of the highly susceptible BALB/c
strain (Hsieh et al., 1995; Reiner and Locksley, 1995), inIL-4 locus by undergoing a functional switch from an
activator to a repressor. For instance, NFAT1 might be that four of five NFAT12/2 mice were eventually able to
control the infection while the BALB/c mice were notthe unique target (within the NFAT family) of a kinase,
phosphatase, or other modifying enzyme that was in- (Figure 6A). Control of L. major infection depends pri-
marily on the effective activation of macrophages byduced late after T cell receptor stimulation, and the
resulting posttranslational modification might inhibit the IFNg and other factors (Reiner and Locksley, 1995), and
susceptibility or resistance to infection with L. major inability of NFAT1 to interact effectively with the general
transcriptional machinery while allowing it to remain BALB/c is linked to several independent chromosomal
loci, indicating a multigenic control of the infectionbound to DNA. Alternatively, NFAT1 might uniquely acti-
vate genes whose products directly or indirectly switch (Beebe et al., 1997). Notably, transcript levels of IFNg
were comparable in cells of the draining lymph nodesoff IL-4 gene transcription late during the response. It
is not unprecedented that a single protein can have both of NFAT11/1 and NFAT12/2 mice (Figure 6B). We suggest
that the early susceptibility of NFAT1-deficient mice topositive and negative effects on a signaling pathway
leading to gene transcription: for instance, ligation of L. major reflects their inability, relative to wild-type mice,
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Flow Cytometryto down-regulate IL-4 transcription effectively. In con-
The fluorescein isothiocyanate (FITC)±labeled monoclonal antibod-trast, additional mechanisms, such as the maintenance
ies (MAbs) anti-CD3, anti-CD8, and anti-Mel-14 (CD62L), as well asof responsiveness to IL-12 (GuÈ ler et al., 1996), may limit the phycoerythrin (PE)±labeled MAb anti-CD4, were purchased from
the further expansion of the infection in the resistant Pharmingen. The MAbs anti-CD25-PE, anti-CD44-PE, anti-CD45RB-
background strains C57BL/6 and 129/SvJ, but not in PE, anti-Mel-14-PE, and anti-CD69-PE (Pharmingen) were kindly
provided by A. Abbas (Harvard Medical School); the biotinylatedBALB/c mice.
MAb against the marker NK1.1 (Pharmingen) was a gift from F. AltIn summary, we have shown that the transcriptional
(Harvard Medical School). Unseparated spleen and lymph node cellsactivator NFAT1 controls, either directly or indirectly,
or purified CD41 T cells were stained for 30 min at 48C, washed,the late down-regulation of IL-4 gene transcription.
and either fixed with 1% paraformaldehyde or analyzed directly
These data constitute evidence that NFAT proteins regu- on a Becton Dickinson FACScan Flow Cytometer. For cell sorting
late not only the early inductive phase but also the termi- experiments, CD4-purified T cells were stained with the MAb anti-
Mel-14-FITC and sorted on a Flow Cytometer (Epics Elite ESP). Thenation of cytokine gene transcription. Our increasing
sorted cell population was greater than 98% Mel-14high CD41.knowledge of the structure and regulation of NFAT pro-
teins, and thus the prospect of individually targeting
RNase Protection AssayNFAT1, might allow us to bias immune responses specif-
After primary or secondary in vitro stimulation, cells were harvested
ically, with crucial consequences for disease and in- at the indicated time points and the total cellular RNA immediately
fection. extracted (Ultraspec, Houston, TX). Cytokine RNA levels were ana-
lyzed by RNase protection assay using the RiboQuant multiprobe
kit (Pharmingen, San Diego, CA) following the instructions of the
Experimental Procedures manufacturer. In brief, equal amounts of target RNA (3±15 mg) were
hybridized overnight to a 32P-labeled RNA probe, which had been
Mice synthesized in vitro from a multicytokine template set, after which
The generation of NFAT12/2 mice, on a mixed C57BL/6 and 129Sv/J free probe and other single-stranded RNA were digested with
background, has been described (Xanthoudakis et al., 1996). All RNases. The protected mRNAs were purified and resolved on a 6%
mice weremaintained in pathogen-free conditions in barrier facilities denaturing polyacrylamide gel. Transcript levels were quantified by
at the Center For Animal Resources and Comparative Medicine, autoradiography and densitometric scanning (IS-1000 Digital Im-
Harvard Medical School, and were used at an age of 8±12 weeks aging System, Alpha Innotech, San Leandro, CA) of autoradiograms
for experiments. with exposures within the linear range. The cytokine transcripts were
identified by the length of the respective fragments. RNA loading
was estimated by measuring the intensities of protected fragmentsCell Culture Conditions and Reagents
representing two housekeeping genes, those encoding L32 andAll cell cultures were done in Dulbecco's modified Eagle's medium
GAPDH (glyceraldehyde 3-phosphate dehydrogenase).supplemented with 10% fetal calf serum, L-glutamine, streptomycin±
penicillin, nonessential amino acids, sodium pyruvate, vitamins,
ELISAHEPES (all from GIBCO, Gaithersburg, MD), and 5 3 1025 M
Cell culture supernatants of cells activated in vitro in a primary or2-mercaptoethanol (Sigma, St. Louis, MO). Single-cell suspensions
secondary stimulation as described above were collected at 24 andwere prepared from lymph node (inguinal, axillary, brachial, and
48 hr, and cytokine levels for IL-4 and IFNg were analyzed usingcervical) and spleen cells. Where indicated, CD41 T cells were puri-
commercial ELISA kits (Endogen, Woburn, MA) according to thefied using magnetic beads (Dynabeads L3T4, Dynal, Lake Success,
manufacturer's instructions. Calculated values are expressed asNY). After each separation, the efficiency of CD41 cell purification
means 6 SEM.was analyzed by flow cytometry and was routinely greater than
95%. In selected experiments, CD4-purified T cells were further
L. major infectionseparated by cell sorting in Mel-14high and Mel-14low populations (see
Infections were performed with promastigotes of L. major (strainbelow). All experiments were done in parallel using equal numbers
Friedlin V1; courtesy of Dr. Steven Beverley, Harvard Medicalof cells from NFAT11/1 and NFAT12/2 mice.
School) grown in M199 medium supplemented with 10% fetal calfPurified T helper cells (1±10 3 106) or unseparated lymph node
serum and antibiotics. Promastigotes were harvested from earlyand spleen cells (10±20 3 106) were stimulated in vitro at 1±2 3 106
stationary-phase cultures by centrifugation and washed in phos-cells/ml with 1 mg/ml of plate-bound anti-CD3 (2C11; Pharmingen,
phate-buffered saline before use. Female NFAT11/1 and NFAT12/2San Diego, CA) for the indicated time points. In some experiments,
mice (five animals per group) as well as BALB/c control mice wereCsA (2 mM; courtesy of Sandoz Pharma, Basel, Switzerland) was
inoculated with 2 3 106 parasites in the left hind footpad. Designatedadded to the cultures.
mice were injected intraperitoneally with 1 mg of the MAb 11B11For in vitro differentiation assays (Gorham et al., 1996; Kaplan et
(anti-IL-4) 24 hr prior to infection and weekly thereafter with 0.5 mgal., 1996a; Lederer et al., 1996), cells were stimulated with plate-
of the antibody. The course of infection was monitored every fifthbound anti-CD3 alone (default conditions); with anti-CD3 plus 10
day by measuring both footpads with a metric caliper and sub-mg/ml anti-IL-4 (11B11; a gift from the Biological Response Modifiers
tracting the size of the noninjected from the injected footpad. ForProgram, National Cancer Institute, Frederick, MD) and 5 ng/ml
in vitro experiments, three mice per group were injected with L.recombinant IL-12 (courtesy of Hoffmann-La Roche, Nutley, NJ) to
major in both footpads. Four weeks after infection, the mice werepromote Th1 cell differentiation; or with anti-CD3 plus 1000 U/ml
sacrificed, the cells of the popliteal lymph nodes draining the lesionsIL-4 to promote Th2 differentiation (IL-4 was added as supernatant
isolated and pooled within groups, and the total cellular RNA ex-from the cell line I3L6 transfected with a constitutively expressed
tracted immediately. The cytokine mRNA was analyzed by RNasemurine IL-4 cDNA [Tepper et al., 1989]) to direct Th2 cell differentia-
protection assay, as described above.tion. In some experiments, cells were differentiated with anti-CD3
plus anti-IL-4 alone.
All cultures were supplemented with 20 U/ml IL-2 (Collaborative Acknowledgments
Biomedical Products, Bedford, MA) after 24 hr, and fresh medium
(30% of the initial volume) was added after 48 hr of stimulation. We would like to thank the members of our laboratory for helpful
advice and discussions. The authors are especially grateful to A.After 4 days, cells were extensively washed, rested for 24±48 hr in
IL-2 (20 U/ml), counted, and restimulated at 1±2 3 106 cells/ml with Abbas, F. Alt, and members of their laboratories for reagents, proto-
cols and discussions. We thank S. Beverley and F. Guerios-Filho1 mg/ml plate-bound anti-CD3. For the quantitation of cytokine
mRNA or protein,as describedbelow, total cellular RNAwas isolated for providing L. major; A. Sharpe for help with L. major experiments;
Mark Ryan and Alan Flint for cell sorting; A. Cuervo for help withand supernatants were collected at the indicated time points.
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